Hutchmed (China)
HCM
Enerpac Tool
EPAC
Precision Drilling
PDS
4
Teradata Corp
TDC
5
Cars.com
CARS
US Stock MarketDetailed Quotes
PYXS Pyxis Oncology
- 0.935
- -0.045-4.59%
Trading Apr 1 12:31 ET
57.58MMarket Cap-0.71P/E (TTM)
0.988High0.911Low203.96KVolume0.980Open0.980Pre Close192.08KTurnover0.46%Turnover RatioLossP/E (Static)61.59MShares5.74052wk High0.48P/B41.45MFloat Cap0.91152wk Low--Dividend TTM44.34MShs Float19.000Historical High--Div YieldTTM7.87%Amplitude0.911Historical Low0.941Avg Price1Lot Size
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Pyxis Oncology Stock Forum
Breakthrough Cancer Drug Achieves Major Milestones: FDA Fast-Tracks Pyxis's Revolutionary Tumor Treatment
Pyxis Cancer Drug Shows Remarkable 50% Response Rate as FDA Fast-Tracks Development
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY...
Pyxis Oncology Granted FDA Fast Track Designation for Pyx-201 Monotherapy in Patients With Recurrent or Metastatic Head and Neck Cancer
Could This FDA Fast Track for Pyxis Oncology's Novel Cancer Drug Accelerate Treatment Options?
Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
Wednesday, 26th February at 7:30 am
BOSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to PYX-201 for the tre...
No comment yet